Report - LifeSciences BC

Recommendation Twelve:Subject to Recommendation Four, if theTherapeutics Initiative is maintained,action must be taken in the followingareas:the governance, membership andaccountability standards associatedwith the operation of theTherapeutics Initiative will requiresubstantial improvement;· steps must also be taken to renewand revitalize the panel of expertsthe Therapeutics Initiative reliesupon to discharge its obligations;the function of the TherapeuticsInitiative should be focused ontherapeutic evaluation. Activitiesbeyond that core mandate such aspublic education should bereassigned to the PSD's DrugUtilization Unit where anaccountable process can beimplemented to assure the unbiasedand evidence-based practices;the practice of having members ofthe Therapeutics Initiative alsoparticipating in the work of theDrug Benefits Committee should beterminated.THE REPORT OF PHARMACEUTICAL POLICY RECOMMENDATIONS FOR THE MINISTRY OF HEALTH 26 APRIL, 2008